substantial patient care and financial benefits can be greatly increased by using generic names or brand names
Answers
Answer:
High launch prices, with the price of the drug then often increasing over time.
Inadequate competition when market exclusivity ends.
The interaction of market power, health insurance, and the lack of effective incentives for controlling product price.
Hope it will help you
Some doctors are said to receive significant financial incentives from pharmaceutical corporations to recommend their medications.
The high cost of several medicines in India has made treating many common and unusual ailments prohibitive for the poor, putting a burden on even middle-class individuals' finances. Modern antidiabetic, anticoagulation, as well as other medications may cost more than Rs. 100 per day for patients with diabetes or heart disease who may need some medicines for months or for the remainder of their lives. The often-mentioned pharma–physician nexus, a problematic state of affairs, adds to the complexity of the expense of medications to consumers.